| KITE | | Kite Pharma, Inc. | Jonathan M. Peacock | Director | Sep 13, 2017 | Gift | - | 635 | - | 69,739 | Oct 05, 2017, 08:28 PM |
| KITE | | Kite Pharma, Inc. | Jonathan M. Peacock | Director | Oct 03, 2017 | Tender Offer | $180.00 | 67,932 | 12,227,760 | 1,807 | Oct 05, 2017, 08:28 PM |
| KITE | | Kite Pharma, Inc. | Ian T. Clark | Director | Oct 03, 2017 | Tender Offer | $180.00 | 1,776 | 319,680 | 5,324 | Oct 05, 2017, 08:27 PM |
| KITE | | Kite Pharma, Inc. | Joshua A. Kazam | Director | Oct 03, 2017 | Tender Offer | $180.00 | 2,553 | 459,540 | 1,807 | Oct 05, 2017, 08:25 PM |
| KITE | | Kite Pharma, Inc. | Joshua A. Kazam | Director | Oct 03, 2017 | Disposition to Issuer | $180.00 | 70,050 | 12,609,000 | 0 | Oct 05, 2017, 08:25 PM |
| KITE | | Kite Pharma, Inc. | Franz B. Humer | Director | Oct 03, 2017 | Tender Offer | $180.00 | 4,624 | 832,320 | 1,807 | Oct 05, 2017, 08:24 PM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Oct 03, 2017 | Tender Offer | $180.00 | 150,620 | 27,111,600 | 1,807 | Oct 05, 2017, 08:23 PM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Oct 03, 2017 | Tender Offer | $180.00 | 25,065 | 4,511,700 | 0 | Oct 05, 2017, 08:23 PM |
| KITE | | Kite Pharma, Inc. | Steven B. Ruchefsky | Director | Sep 14, 2017 | Gift | - | 2,250 | - | 205,586 | Oct 05, 2017, 08:21 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Sep 29, 2017 | Gift | - | 2,800 | - | 63,274 | Oct 05, 2017, 08:20 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Oct 03, 2017 | Tender Offer | $180.00 | 61,467 | 11,064,060 | 1,807 | Oct 05, 2017, 08:20 PM |
| KITE | | Kite Pharma, Inc. | Owen N. Witte | Director | Sep 18, 2017 | Gift | - | 12,000 | - | 64,250 | Oct 05, 2017, 08:19 PM |
| KITE | | Kite Pharma, Inc. | Owen N. Witte | Director | Oct 03, 2017 | Tender Offer | $180.00 | 58,535 | 10,536,300 | 5,715 | Oct 05, 2017, 08:19 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Oct 03, 2017 | Tender Offer | $180.00 | 3,927 | 706,860 | 41,734 | Oct 05, 2017, 08:17 PM |
| KITE | | Kite Pharma, Inc. | Shawn Tomasello | Chief Commercial Officer | Sep 25, 2017 | Gift | - | 5,000 | - | 56,068 | Oct 05, 2017, 08:16 PM |
| KITE | | Kite Pharma, Inc. | Shawn Tomasello | Chief Commercial Officer | Oct 03, 2017 | Tender Offer | $180.00 | 16,135 | 2,904,300 | 39,933 | Oct 05, 2017, 08:16 PM |
| KITE | | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Oct 03, 2017 | Tender Offer | $180.00 | 14,674 | 2,641,320 | 11,150 | Oct 05, 2017, 08:15 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Oct 03, 2017 | Tender Offer | $180.00 | 4,193 | 754,740 | 17,500 | Oct 05, 2017, 08:14 PM |
| KITE | | Kite Pharma, Inc. | Paul L. Jenkinson | Chief Financial Officer | Oct 03, 2017 | Disposition to Issuer | $180.00 | 3,000 | 540,000 | 0 | Oct 05, 2017, 08:13 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 11, 2017 | Gift | - | 375 | - | 57,048 | Oct 05, 2017, 08:12 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 12, 2017 | Gift | - | 1,041 | - | 56,007 | Oct 05, 2017, 08:12 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 13, 2017 | Gift | - | 157 | - | 55,850 | Oct 05, 2017, 08:12 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 20, 2017 | Gift | - | 570 | - | 55,280 | Oct 05, 2017, 08:12 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Oct 03, 2017 | Tender Offer | $180.00 | 16,605 | 2,988,900 | 38,675 | Oct 05, 2017, 08:12 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Sep 21, 2017 | Gift | - | 27,900 | - | 93,667 | Oct 05, 2017, 08:11 PM |
| KITE | | Kite Pharma, Inc. | Arie Belldegrun | Chairman, President and CEO | Oct 03, 2017 | Disposition to Issuer | $180.00 | 3,197,269 | 575,508,420 | 0 | Oct 05, 2017, 08:10 PM |
| KITE | | Kite Pharma, Inc. | Shawn Tomasello | Chief Commercial Officer | Sep 25, 2017 | Sale | $179.66 | 4,203 | 755,128 | 61,068 | Sep 27, 2017, 09:44 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Sep 25, 2017 | Sale | $179.66 | 3,171 | 569,715 | 21,693 | Sep 27, 2017, 09:43 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Mar 15, 2017 | Sale | $83.31 | 7,511 | 625,741 | 41,889 | Sep 27, 2017, 09:42 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Sep 25, 2017 | Sale | $179.66 | 4,228 | 759,619 | 45,661 | Sep 27, 2017, 09:42 PM |
| KITE | | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Sep 25, 2017 | Sale | $179.66 | 5,283 | 949,165 | 25,824 | Sep 27, 2017, 09:41 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Sep 25, 2017 | Sale | $179.66 | 7,927 | 1,424,197 | 57,423 | Sep 27, 2017, 09:40 PM |
| KITE | | Kite Pharma, Inc. | Paul L. Jenkinson | Chief Financial Officer | Sep 25, 2017 | Sale | $179.66 | 948 | 170,321 | 9,462 | Sep 27, 2017, 09:39 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Sep 25, 2017 | Sale | $179.66 | 4,228 | 759,619 | 121,567 | Sep 27, 2017, 09:38 PM |
| KITE | | Kite Pharma, Inc. | Arie Belldegrun | Chairman, President and CEO | Sep 25, 2017 | Sale | $179.66 | 26,347 | 4,733,607 | 109,160 | Sep 27, 2017, 09:38 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 10, 2017 | Option/RSU Exercise | $52.85 | 6,251 | 330,369 | 24,915 | Aug 14, 2017, 05:04 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 10, 2017 | Sale | $120.09 | 6,251 | 750,683 | 18,664 | Aug 14, 2017, 05:04 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Aug 10, 2017 | Option/RSU Exercise | $1.35 | 15,000 | 20,250 | 132,795 | Aug 14, 2017, 05:03 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Aug 10, 2017 | Sale | $120.72 | 15,000 | 1,810,758 | 123,595 | Aug 14, 2017, 05:03 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 08, 2017 | Sale | $119.56 | 79,949 | 9,558,324 | 87,539 | Aug 10, 2017, 04:57 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Aug 08, 2017 | Option/RSU Exercise | $53.90 | 79,949 | 4,309,251 | 98,613 | Aug 10, 2017, 04:57 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Aug 03, 2017 | Option/RSU Exercise | $44.91 | 6,000 | 269,460 | 55,400 | Aug 04, 2017, 07:50 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Aug 03, 2017 | Sale | $110.06 | 6,000 | 660,343 | 54,531 | Aug 04, 2017, 07:50 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Aug 01, 2017 | Option/RSU Exercise | $44.91 | 3,000 | 134,730 | 61,400 | Aug 03, 2017, 09:14 PM |
| KITE | | Kite Pharma, Inc. | Timothy L. Moore | EVP, Technical Operations | Aug 01, 2017 | Sale | $107.69 | 12,000 | 1,292,322 | 58,923 | Aug 03, 2017, 09:14 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Jul 31, 2017 | Option/RSU Exercise | $52.96 | 26,649 | 1,411,437 | 45,313 | Aug 01, 2017, 07:00 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Jul 31, 2017 | Sale | $109.28 | 26,649 | 2,912,272 | 29,509 | Aug 01, 2017, 07:00 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jul 10, 2017 | Option/RSU Exercise | $1.35 | 15,000 | 20,250 | 132,795 | Jul 11, 2017, 05:36 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jul 10, 2017 | Sale | $103.09 | 15,000 | 1,546,300 | 129,448 | Jul 11, 2017, 05:36 PM |
| KITE | | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jul 03, 2017 | Sale | $104.32 | 10,000 | 1,043,201 | 22,272 | Jul 06, 2017, 06:15 PM |
| KITE | | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Jul 03, 2017 | Option/RSU Exercise | $6.89 | 10,000 | 68,900 | 31,071 | Jul 06, 2017, 06:15 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 23, 2017 | Option/RSU Exercise | $1.35 | 5,000 | 6,750 | 122,795 | Jun 27, 2017, 07:07 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 23, 2017 | Sale | $100.81 | 5,000 | 504,033 | 119,845 | Jun 27, 2017, 07:07 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 23, 2017 | Sale | $100.81 | 5,000 | 504,033 | 114,845 | Jun 27, 2017, 12:25 PM |
| KITE | | Kite Pharma, Inc. | Owen N. Witte | Director | Jun 23, 2017 | Sale | $100.00 | 12,500 | 1,250,000 | 88,750 | Jun 26, 2017, 07:55 PM |
| KITE | | Kite Pharma, Inc. | Owen N. Witte | Director | Jun 26, 2017 | Sale | $100.60 | 12,500 | 1,257,500 | 76,250 | Jun 26, 2017, 07:55 PM |
| KITE | | Kite Pharma, Inc. | Owen N. Witte | Director | Jun 23, 2017 | Option/RSU Exercise | $18.00 | 12,500 | 225,000 | 101,250 | Jun 26, 2017, 07:55 PM |
| KITE | | Kite Pharma, Inc. | Steven B. Ruchefsky | Director | Jun 14, 2017 | Sale | $89.48 | 20,000 | 1,789,574 | 205,426 | Jun 16, 2017, 05:43 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Jun 14, 2017 | Sale | $90.40 | 15,000 | 1,356,000 | 63,664 | Jun 16, 2017, 05:41 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Jun 16, 2017 | Sale | $88.11 | 5,450 | 480,200 | 0 | Jun 16, 2017, 05:41 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 09, 2017 | Sale | $88.55 | 10,000 | 885,491 | 127,395 | Jun 12, 2017, 07:16 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Jun 09, 2017 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Jun 12, 2017, 07:16 PM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Jun 07, 2017 | Sale | $84.46 | 10,000 | 844,621 | 155,017 | Jun 09, 2017, 09:11 PM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Jun 08, 2017 | Sale | $84.53 | 5,000 | 422,634 | 150,017 | Jun 09, 2017, 09:11 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Jun 01, 2017 | Option/RSU Exercise | $51.43 | 2,400 | 123,432 | 21,064 | Jun 05, 2017, 05:05 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Jun 01, 2017 | Sale | $72.45 | 2,400 | 173,880 | 18,664 | Jun 05, 2017, 05:05 PM |
| KITE | | Kite Pharma, Inc. | Ran Nussbaum | Director | May 09, 2017 | Buy | $69.11 | 9,832 | 679,474 | 3,520 | May 11, 2017, 02:02 PM |
| KITE | | Kite Pharma, Inc. | Paul L. Jenkinson | Chief Financial Officer | May 10, 2017 | Buy | $72.57 | 450 | 32,656 | 7,480 | May 10, 2017, 03:12 PM |
| KITE | | Kite Pharma, Inc. | Paul L. Jenkinson | Chief Financial Officer | May 10, 2017 | Buy | $72.59 | 3,000 | 217,770 | 3,000 | May 10, 2017, 03:12 PM |
| KITE | | Kite Pharma, Inc. | Steven B. Ruchefsky | Director | May 09, 2017 | Buy | $69.50 | 1,400 | 97,300 | 225,426 | May 10, 2017, 12:52 PM |
| KITE | | Kite Pharma, Inc. | David Bonderman | Director | May 09, 2017 | Buy | $68.94 | 50,000 | 3,446,997 | 2,408,084 | May 09, 2017, 06:29 PM |
| KITE | | Kite Pharma, Inc. | Arie Belldegrun | Chairman, President and CEO | May 09, 2017 | Buy | $68.57 | 17,000 | 1,165,690 | 85,507 | May 09, 2017, 03:37 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | May 01, 2017 | Option/RSU Exercise | $53.90 | 2,400 | 129,360 | 21,064 | May 03, 2017, 06:08 PM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | May 01, 2017 | Sale | $82.12 | 2,400 | 197,088 | 18,664 | May 03, 2017, 06:08 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | May 01, 2017 | Option/RSU Exercise | $6.89 | 20,000 | 137,800 | 70,165 | May 03, 2017, 06:06 PM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | May 01, 2017 | Sale | $82.09 | 20,000 | 1,641,744 | 56,370 | May 03, 2017, 06:06 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 27, 2017 | Sale | $82.77 | 16,551 | 1,369,926 | 7,579 | May 01, 2017, 06:52 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 28, 2017 | Sale | $82.59 | 2,617 | 216,138 | 4,962 | May 01, 2017, 06:52 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Apr 25, 2017 | Option/RSU Exercise | $1.35 | 15,000 | 20,250 | 132,795 | Apr 27, 2017, 06:49 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Apr 25, 2017 | Sale | $81.85 | 15,000 | 1,227,690 | 127,082 | Apr 27, 2017, 06:49 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 25, 2017 | Sale | $82.80 | 46,783 | 3,873,585 | 90,758 | Apr 26, 2017, 05:38 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 26, 2017 | Sale | $82.72 | 51,312 | 4,244,597 | 24,330 | Apr 26, 2017, 05:38 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 24, 2017 | Sale | $82.34 | 25,818 | 2,125,854 | 122,225 | Apr 26, 2017, 05:38 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 13, 2017 | Sale | $82.39 | 72,275 | 5,954,737 | 191,144 | Apr 17, 2017, 09:24 PM |
| KITE | | Kite Pharma, Inc. | Farah Champsi | Director | Apr 17, 2017 | Sale | $82.48 | 43,101 | 3,555,029 | 148,143 | Apr 17, 2017, 09:24 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Apr 03, 2017 | Option/RSU Exercise | $1.35 | 5,000 | 6,750 | 122,795 | Apr 04, 2017, 04:15 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Apr 03, 2017 | Sale | $81.96 | 5,000 | 409,798 | 120,995 | Apr 04, 2017, 04:15 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Mar 27, 2017 | Option/RSU Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Mar 28, 2017, 07:57 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Mar 27, 2017 | Sale | $77.67 | 10,000 | 776,746 | 127,495 | Mar 28, 2017, 07:57 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Mar 09, 2017 | Option/RSU Exercise | $1.35 | 21,118 | 28,509 | 138,913 | Mar 10, 2017, 05:25 PM |
| KITE | | Kite Pharma, Inc. | Cynthia M. Butitta | Chief Operating Officer | Mar 09, 2017 | Sale | $80.78 | 21,118 | 1,705,929 | 126,786 | Mar 10, 2017, 05:25 PM |
| KITE | | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Mar 01, 2017 | Sale | $75.01 | 18,000 | 1,350,144 | 38,997 | Mar 02, 2017, 06:09 AM |
| KITE | | Kite Pharma, Inc. | Jeffrey Wiezorek | SVP Clinical Development | Mar 01, 2017 | Option/RSU Exercise | $6.89 | 18,000 | 124,020 | 39,071 | Mar 02, 2017, 06:09 AM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Mar 01, 2017 | Option/RSU Exercise | $6.89 | 60,000 | 413,400 | 110,165 | Mar 02, 2017, 06:08 AM |
| KITE | | Kite Pharma, Inc. | David D. Chang | EVP, R&D, Chief Medical Off. | Mar 01, 2017 | Sale | $79.16 | 60,000 | 4,749,441 | 54,900 | Mar 02, 2017, 06:08 AM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Mar 01, 2017 | Option/RSU Exercise | $1.35 | 50,000 | 67,500 | 75,065 | Mar 02, 2017, 06:06 AM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Mar 01, 2017 | Sale | $74.05 | 16,000 | 1,184,873 | 121,017 | Mar 02, 2017, 06:06 AM |
| KITE | | Kite Pharma, Inc. | Roy Doumani | Director | Mar 01, 2017 | Sale | $76.76 | 2,800 | 214,942 | 25,065 | Mar 02, 2017, 06:06 AM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Feb 28, 2017 | Sale | $67.40 | 47,900 | 3,228,372 | 64,164 | Mar 02, 2017, 06:05 AM |
| KITE | | Kite Pharma, Inc. | Helen Susan Kim | EVP, Business Development | Mar 01, 2017 | Option/RSU Exercise | $53.90 | 2,400 | 129,360 | 21,064 | Mar 02, 2017, 06:05 AM |
